Yixin Zhang - Publications

Targeting the TRIM25-AGO2-miR-148b-5p-ABCC1 axis overcomes chemoresistance in non-small cell lung cancer.

Journal: Cell death & disease

Published: October 20, 2025

The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs.

Journal: Nucleic acids research

Published: June 24, 2024

USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization.

Journal: CNS neuroscience & therapeutics

Published: November 17, 2023

Invariant chain of the MAIT-TCR vα7.2-Jα33 as a novel diagnostic biomarker for keloids.

Journal: Experimental dermatology

Published: April 16, 2022

Effect of free deep inferior epigastric artery perforator flap transplantation in breast shaping of two-staged breast reconstruction with vertical scar

Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery

Published: October 15, 2021

Identification and Validation of Novel Diagnostic Biomarkers for Keloid Based on GEO Database.

Journal: International journal of general medicine

Published: September 30, 2021

Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.

Journal: Frontiers in oncology

Published: August 02, 2021

Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis.

Journal: BMC cancer

Published: June 19, 2021

Non-invasive optical methods for melanoma diagnosis.

Journal: Photodiagnosis and photodynamic therapy

Published: January 30, 2021

Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC.

Journal: Molecular therapy oncolytics

Published: April 21, 2020

CD26 upregulates proliferation and invasion in keloid fibroblasts through an IGF-1-induced PI3K/AKT/mTOR pathway.

Journal: Burns & trauma

Published: November 19, 2019

Inhibition of LncRNAH19 has the effect of anti-tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non-small-cell lung cancer in vivo.

Journal: Journal of cellular and molecular medicine

Published: October 12, 2019